News for AnteoTech Limited (ADO.AX)

Published at

Jul 21, 2025 4:38 AM

by themarketherald.com.au

positive

positive

Monday’s HotCopper Trends: Strike Energy pause, Anteotech’s US team-up | July 21

Long-followed HotCopper forums darling Strike Energy (ASX:STX) has been the talk of…

STX.AX ADO.AX

Read more →
Published at

Feb 27, 2025 6:00 AM

by gurufocus.com

positive

positive

AnteoTech Ltd (ASX:ADO) (H1 2025) Earnings Call Highlights: Transition to Market-Driven Success

Release Date: February 26, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points AnteoTech Lt

ADO.AX

Read more →
Published at

Feb 27, 2025 5:05 AM

by gurufocus.com

neutral

neutral

Half Year 2025 Anteotech Ltd Earnings Call Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NADO.AX - Anteotech LtdHalf Year 2025 Anteotech Ltd Earnings CallFeb 26, 2025 / 12:00AM GMT ===

ADO.AX

Read more →
Published at

Oct 18, 2024 5:43 AM

by themarketherald.com.au

mixed

mixed

Week 42 Wrap: HotCopper’s top picks; new ASX200 record; world yawns at war

Looking at what HotCopper was watching this week, it felt a bit like 2022 – a lithium explorer and a battery anode developer won the cake.

RDN.AX ADO.AX NVDA.MI

Read more →
Published at

Oct 15, 2024 4:42 AM

by smallcaps.com.au

positive

positive

AnteoTech receives first commercial order for Ultranode silicon battery from European EV maker

Queensland-based chemistry company AnteoTech (ASX: ADO) has received a $40,000 commercial order for its proprietary Ultranode 70%-silicon battery anode

ADO.AX

Read more →
Published at

Sep 14, 2024 3:00 AM

by gurufocus.com

positive

positive

AnteoTech Ltd (ASX:ADO) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Investments

Cash: $5 million at the end of FY 2024.R&D Rebate: $3.8 million received during the year.Operating Revenues: Up 28% compared to the previous year.Base Cost Red

ADO.AX

Read more →
Published at

Jul 30, 2024 1:04 AM

by themarketherald.com.au

positive

positive

ASX Market Open: Local bourse to fall as world awaits Fed call | July 30

The ASX200 is set to fall nearly three quarters of a percent following cues from Wall Street.

SGR.AX ADO.AX

Read more →
Published at

Mar 28, 2024 10:26 PM

by gurufocus.com

positive

positive

Anteotech Ltd Annual Shareholders Meeting Transcript

Nov 14, 2023 / 12:00AM GMTEwen Crouch Anteotech Ltd-Chairman Good morning, everyone. My name is Ewen Crouch, and I'm Chairman of antibiotic Limited. I would lik

ADO.AX

Read more →
Published at

Mar 28, 2024 10:26 PM

by gurufocus.com

positive

positive

Anteotech Ltd at ASX Small and Mid-Cap Conference Transcript

Sep 20, 2023 / 03:20AM GMTAndrew Scott - Proactive - Moderator The ASX Small and Mid-Cap Conference this afternoon. David Radford from AnteoTech .David, good to

ADO.AX

Read more →
Published at

Mar 27, 2024 7:05 AM

by themarketherald.com.au

positive

positive

Market Close: ASX eases up as staple sector shines

The ASX200 closed up just over half a per cent led by staples, healthcare and industrials.

TLM.AX OSX.AX BWP.AX ADO.AX

Read more →
Published at

Jul 26, 2023 8:54 AM

by themarketherald.com.au

mixed

mixed

TMH Market Close: Inflation eases to 6pc in June quarter

Australia’s June quarterly inflation rate dropped to 6 per cent from 7 per cent in the March quarter.

SOM.AX ADO.AX KTA.AX ASB.AX

Read more →
Published at

Jul 26, 2023 6:32 AM

by themarketherald.com.au

positive

positive

AnteoTech (ASX:ADO) taps investors for $6m via placement and SPP

AnteoTech (ASX:ADO) has tapped sophisticated and professional investors for $6 million through a placement and SPP.

ADO.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Dec 22, 2022 3:01 PM

by stockhead.com.au

mixed

mixed

After a dismal year for ASX health stocks 2023 is showing signs of a recovery

The ASX health sector is down more than 8% as 2022 comes to end but in signs of optimism for 2023, Morgans has a basket of stocks to watch.

TD1.AX PME.AX NURPF NEU.AX NAN.AX MEM.AX KZIA KZA.AX HXL.AX HHI.AX EX1.AX SCU.AX PIQ.AX OSL.AX MVF.AX EBO.NZ EBO.AX CSLN.MX CSLLY CSL.AX CMXHF BXPHF BOT.AX AVR.AX AMEUF AJJ.AX ADO.AX ZLDAF ZLD.AX WFL.AX VIP.AX VHT.AX UBI.AX SIG.AX REG.AX PNV.AX PBP.AX OVN.AX NTI.AX MEB.AX MDBIF LCT.AX CSX.AX CRON CPH.AX COPHF CAU.AX CALZF AT1.AX ARX.AX ANR.AX

Read more →
Published at

Nov 30, 2022 8:10 PM

by stockhead.com.au

mixed

mixed

Check Up: The world's most expensive drug costs $3.5 MILLION a shot

The US FDA has just approved the world’s most expensive drug. CSL Behring’s hemophilia B gene therapy costs US$3.5m a dose.

PAB.AX OCC.AX NC6.AX MDR.AX IMM.AX GTG.AX GSS.AX EYE.AX CSLN.MX CSLLY CSL.AX CMXHF BPH.AX SHL.AX RAC.AX PSQ.AX ONE.AX NYR.AX NXSCF NXS.AX MXC.AX KZA.AX FDMDF DXB.AX DVL.AX CYP.AX CPH.AX CGS.AX AT1.AX ARX.AX ARUXF AMDHF ALC.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RHT.AX RGS.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PBP.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OIL.AX NOXOF NOX.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GLH.AX CMP.AX CKDXF CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX AMT.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →
Published at

Nov 23, 2022 7:50 PM

by stockhead.com.au

mixed

mixed

How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have fallen out of favour in 2022 with a a rotation out of growth into value sectors but could it also do with better PR?

VTG.AX NEU.AX MXC.AX KZA.AX CSL.AX COH.AX BWXXF BWX.AX AT1.AX ADR.AX ADO.AX ZNO.AX ZLD.AX UBI.AX TD1.AX SHL.AX RSH.AX RHT.AX RAC.AX PNV.AX PBP.AX OVN.AX OSX.AX OSL.AX OCC.AX NOXOF NOX.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IUGNF IMU.AX ICS.AX ICR.AX EYE.AX CPH.AX CMP.AX CALZF BXN.AX AMDHF 1ST.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OPT.AX OPT ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDR.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX IDT.AX HCT.AX GTG.AX GSS.AX GLH.AX FDMDF DXB.AX DVL.AX CYP.AX CKDXF CGS.AX CAN.AX CAJ.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Nov 2, 2022 8:30 PM

by stockhead.com.au

mixed

mixed

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations

Four ASX healthcare stocks have been rated as a ‘Strong Buy' by Morningstar’s consensus of brokers, making them hot tips.

ZNO.AX RHT.AX LBT.AX KZA.AX IUGNF IMU.AX ICR.AX EPN.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 1ST.AX ZLD.AX RAC.AX PNV.AX PBP.AX ONE.AX OIL.AX NXSCF NXS.AX MDR.AX IPDQF IPD.AX IMRNW IMRN IMC.AX GTG.AX GSS.AX GLH.AX FDMDF EYE.AX CYP.AX CALZF BNOEF BNO.AX 4DX.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IMM.AX IHL.AX IDT.AX HCT.AX DXB.AX DVL.AX CPH.AX CMP.AX CKDXF CGS.AX CAN.AX CAJ.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX AT1.AX AMDHF ADR.AX ADO.AX 1AD.AX

Read more →